The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1)

EDITORIAL  SECOND GENERATION PET TRACERS IN ONCOLOGY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):1-3

PET beyond 18F-FDG: second generation PET tracers in clinical oncology

Brouwers A. H., Glaudemans A. W. J. M., De Vries E. F. J.

PDF

REVIEWS  SECOND GENERATION PET TRACERS IN ONCOLOGY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):4-17

Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone

Talbot J. N., Gligorov J., Nataf V., Montravers F., Huchet V., Michaud L., Ohnona J., Balogova S., Cussenot O., Daraï E., Lotz J. P., Kerrou K.

Abstract PDF

REVIEWS  SECOND GENERATION PET TRACERS IN ONCOLOGY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):18-38

89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied?

Van Dongen G. A., Huisman M. C., Boellaard R., Harry Hendrikse N., Windhorst A. D., Visser G. W., Molthoff C. F., Vugts D. J.

Abstract PDF

REVIEWS  SECOND GENERATION PET TRACERS IN ONCOLOGY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):39-57

Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles

Peeters S. G., Zegers C. M., Yaromina A., Van Elmpt W., Dubois L., Lambin P.

Abstract PDF

REVIEWS  SECOND GENERATION PET TRACERS IN ONCOLOGY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):58-69

Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP)

Ambrosini V., Morigi J. J., Nanni C., Castellucci P., Fanti S.

Abstract PDF

REVIEWS  SECOND GENERATION PET TRACERS IN ONCOLOGY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):70-82

Applications of PET imaging of neurological tumors with radiolabeled amino acids

Galldiks N., Langen K. J.

Abstract PDF

REVIEWS  SECOND GENERATION PET TRACERS IN ONCOLOGY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):83-94

Applications of PET imaging with radiolabelled choline (11C/18F-choline)

Kirienko M., Sollini M., Lopci E., Versari A., Chiti A.

Abstract PDF

REVIEWS  SECOND GENERATION PET TRACERS IN ONCOLOGY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):95-104

Applications of PET imaging with the proliferation marker [18F]-FLT

Peck M., Pollack H. A., Friesen A., Muzi M., Shoner S. C., Shankland E. G., Fink J. R., Armstrong J. O., Link J. M., Krohn K. A.

Abstract PDF

REVIEWS  SECOND GENERATION PET TRACERS IN ONCOLOGY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):105-15

Current status of PET imaging of differentiated thyroid cancer with second generation radiopharmaceuticals

Lauri C., Di Traglia S., Galli F., Pizzichini P., Signore A.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):116-20

Comparison of 68Ga-DOTATOC biodistribution in patients with and without spleenectomy

Kratochwil C., Mavriopoulou E., Rath D., Afshar-Oromieh A., Apostolopoulos D., Haufe S., Mier W., Haberkorn U., Giesel F. L.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):121-8

Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis

Fu H., Ma C., Tang L., Wu F., Liu B., Wang H.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):129-35

Precise fusion of MRI and dual energy 111In WBC/99mTc HDP SPECT/CT in the diabetic foot using companion CT: an example of SPECT/MRI imaging

Knešaurek K., Kolker D., Vatti S., Heiba S.

Abstract PDF